Bright Minds Biosciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Bright Minds Biosciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bright Minds Biosciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bright Minds Biosciences Inc. is DRUG:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bright Minds Biosciences Inc. has its primary listing on NASDAQ (Small cap). You can trade Bright Minds Biosciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bright Minds Biosciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bright Minds Biosciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bright Minds Biosciences Inc..